-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
CUHK's participation in the study found that delaying the operation of COVID-19 patients by seven weeks can reduce the risk of death |
China News Service, Hong Kong, March 23 (Reporter Han Xingtong) The Chinese University of Hong Kong (CUHK) announced on the 23rd that a joint study by CUHK and overseas surgical experts found that if a patient diagnosed with new coronary pneumonia undergoes surgery within six weeks after diagnosis, they will Increasing the risk of postoperative death, research suggests that the operation should be postponed to the seventh week or later after diagnosis.
Hong Kong Hong Kong
It is reported that the study was conducted by 45 experts from the Department of Surgery, Department of Anesthesiology and Intensive Care Medicine of the Faculty of Medicine of CUHK, and doctors from the New Territories East Network of the Hong Kong Hospital Authority, together with the COVIDSurg Collaborative composed of more than 15,000 surgical experts around the world.
Hong Kong
The study collected 140,727 patient data from 116 countries and 1674 hospitals, covering Asia, America, Europe, Africa and Oceania.
The research team found that patients undergoing surgery within six weeks of diagnosis and their symptoms have not resolved will have a higher risk of postoperative death.
Professor Wu Zhaowen of the Department of Surgery at the Faculty of Medicine of CUHK said that Hong Kong has so far more than 11,000 confirmed cases of new coronary pneumonia.
Hong Kong aspx?id=3570" target="_blank" style="color:#ba1413">focuses on COVID-19